Auf dem neuesten Stand? – Allergische Dermatitis bei der Katze

Allergische Dermatitiden sind ein multifaktorielles Krankheitsgeschehen. Nur eine Kombination verschiedener Therapieansätze ermöglicht der Katze eine gute Lebensqualität. Dabei gilt es, Stress zu minimieren sowie kausale und symptomatische Therapien zu kombinieren.

Publikationsverlauf

Artikel online veröffentlicht:
23. Juni 2020

• Literatur

• 1 Halliwell R. Revised nomenclature for veterinary allergy. Vet Immunol Immunopathol 2006; 114(3 – 4): 207-208
• 2 Olivry T, DeBoer DJ, Griffin CE. et al. The ACVD task force on canine atopic dermatitis: forewords and lexicon. Vet Immunol Immunopathol 2001; 81: 143-146
• 3 Favrot C, Steffan J, Seewald W. et al. Establishment of diagnostic criteria for feline nonflea-induced hypersensitivity dermatitis. Vet Dermatol 2012; 23: 45-50
• 4 Hobi S, Linek M, Marignac G. et al. Clinical characteristics and causes of pruritus in cats: a multicentre study on feline hypersensitivity-associated dermatoses. Vet Dermatol 2011; 22: 406-413
• 5 Trimmer AM, Griffin CE, Boord MJ. et al. Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats. Vet Dermatol 2005; 16 (05) 324-329
• 6 Wildermuth K, Zabel S, Rosychuk RA. The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study. Vet Dermatol 2013; 24: 576-581
• 7 Scarampella F, Abramo F, Noli C. Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study. Vet Dermatol 2001; 12: 29-39
• 8 Maina E, Fontaine J. Use of maropitant for the control of pruritus in non-flea, non-food-induced feline hypersensitivity dermatitis: an open-label, uncontrolled pilot study. J Feline Med Surg 2019; 21 (10) 967-972
• 9 King S, Favrot C, Messinger L. et al. A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis. Vet Dermatol 2012; 23: 440-484
• 10 Noli C, Scarampella F. Prospective open pilot study on the use of ciclosporine for feline allergic skin disease. J Small Anim Pract 2006; 47: 434-438
• 11 Last RD, Suzuki Y, Manning T. et al. A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporin A for feline atopy. Vet Dermatol 2004; 15: 194-198
• 12 Gonzales AJ, Bowman JW, Fici GJ. et al. Oclacitinib (APOQUEL(^®)) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther 2014; 37 (04) 317-324
• 13 Ortalda C, Noli C, Colombo S, Borio S. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats. Vet Dermatol 2015; 26 (04) 235-e52 doi:10.1111/vde.12218
• 14 Lopes NL, Campos DR, Machado MA. et al. A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats. BMC Vet Res 2019; 15 (01) 137
• 15 Noli C, Matricoti I, Schievano C. A double-blinded, randomized, methylprednisolone-controlled study on the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis. Vet Dermatol 2019; 30: 110-130
• 16 Neuber A, Shaw SC. Topical application of hydrocortisone aceponate spray (Cortavance^®) for the treatment of pemphigus foliaceus in a cat. Wiener Tierarztl Monatsschrift 2011; 98 (07) 156-159
• 17 Schmidt V, Buckley LM, McEwan NA. et al. Efficacy of a 0.0584 % hydrocortisone aceponate spray in presumed feline allergic dermatitis: an open label pilot study. Vet Dermatol 2012; 23: 11-16
• 18 Moon MY, Suh GH, Guk-Hyun S, Kwon YJ. et al. Effective treatment of eosinophilic granuloma in a cat using tacrolimus with prednisolone. J Biomed Translat Res 2017; 18: 118-120
• 19 Wildermuth BE, Griffin CE, Rosenkrantz WS. Response of feline eosinophilic plaques and lip ulcers to amoxicillin trihydrate-clavulanate potassium therapy: a randomized, double-blind placebo-controlled prospective study. Vet Dermatol 2012; 23: 110-118